Evaluation of the safety and tolerability of a short higher-dose primaquine regimen for presumptive anti-relapse therapy in healthy subjects.
about
Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquineThe intestinal microbiome in spondyloarthritisKilling the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivaxPharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria.Use of quantitative pharmacology tools to improve malaria treatments.
P2860
Evaluation of the safety and tolerability of a short higher-dose primaquine regimen for presumptive anti-relapse therapy in healthy subjects.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluation of the safety and t ...... e therapy in healthy subjects.
@ast
Evaluation of the safety and t ...... e therapy in healthy subjects.
@en
Evaluation of the safety and t ...... e therapy in healthy subjects.
@nl
type
label
Evaluation of the safety and t ...... e therapy in healthy subjects.
@ast
Evaluation of the safety and t ...... e therapy in healthy subjects.
@en
Evaluation of the safety and t ...... e therapy in healthy subjects.
@nl
prefLabel
Evaluation of the safety and t ...... e therapy in healthy subjects.
@ast
Evaluation of the safety and t ...... e therapy in healthy subjects.
@en
Evaluation of the safety and t ...... e therapy in healthy subjects.
@nl
P2093
P1476
Evaluation of the safety and t ...... e therapy in healthy subjects.
@en
P2093
Andrew Ebringer
Gary Heathcote
Joanne Baker
Michael D Edstein
P304
P356
10.1016/J.TRSTMH.2011.07.001
P577
2011-09-03T00:00:00Z